Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors while in the central nervous program, conolidine modulates alternate molecular targets. A Science Innovations research identified that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://williamv431dfg2.sasugawiki.com/user